Drug giant Merck announces lower prices on some medications

Drug giant Merck announces lower prices on some medications

Pfizer's July 1 hike was already its second this year after it raised prices on 41 drugs in January, according to Wells Fargo analyst David Maris, FiercePharma reported.

President Trump once again honed in on the high cost of US prescription drugs on Thursday morning, praising Novartis and Pfizer for their recent decisions not to raise prices.

Merck said it's cutting the price of Zepatier, a drug that treats hepatitis C, by 60% and reducing the price of six other medications by 10% each.

Trump has promised to lower drug prices since the campaign and as is his style, has resorted to calling out companies by name on Twitter after reports of price increases.

Merck also says it will not raise the average price of drugs beyond the annual rate of inflation.

Roche, Bayer and Merck KGaA all said on Friday they would not seek to lift prices this year in the world's biggest drug market, following Novartis, Pfizer and USA drugmaker Merck which had already announced similar moves.

In 2017 it priced Ocrevus at $65,000 annually, undercutting German rival Merck KGaA's Rebif by a quarter even though Ocrevus beat Rebif in a trial.

Last night also Merck & Co responded to the president's appeal.

Earlier this month, the president was able to persuade Pfizer CEO Ian Read to defer the company's planned price hikes, explaining in a call that the company had complicated the administration's drug pricing plans.

Pfizer's and Novartis' tactics don't guarantee long-standing commitments to voluntarily reduce or halt drug price increases, either, and won't necessarily translate into lower prices for American patients, given the convoluted nature of the pharmaceutical supply chain. That prompted a tweet by Trump saying the company should be "ashamed" and promising an unspecified response.

After the meeting, Pfizer said it would hold off on increasing prices until the administration releases its drug pricing plan or the end of the year, whichever comes first.

Trump announced in May a plan to lower drug prices by, among other things, giving the government better tools to negotiate drug prices for Medicare beneficiaries and counter foreign government regulations that often keep drug prices artificially low. Pharmaceutical company stocks rose after the blueprint was announced.



Related Posts

Trump ups tariff threat, slams Fed, big U.S. trading partners
Trump said he was not thrilled the Fed was raising rates. "I want them to do well", the USA president said of China . The last known example of U.S. presidential strong-arming came when George H W Bush was fighting for re-election.

After Helsinki, Senate GOP Quietly Takes Aim at Russian Federation
But Coons and Flake barely got out of the gate on the Senate floor. "I think it's regrettable that this was objected to". "If ever there was a moment to think not of just your party but for the country, this is it", Sen.

Former champion Nibali out of Tour after crash
However, the Welshman did, for a third straight day, hear boos as he collected his yellow jersey. "My back hurts. When Dumoulin attacked with two kilometres remaining, Thomas chased him down with Froome towing along.

Trudeau shuffles Cabinet, seeking to reduce Canada's reliance on US
But Trudeau did not promote anyone from the province to replace Kent Hehr, leaving Alberta with one seat at the cabinet table. Now the first-time minister just needs to find a way to appease Quebecers angry at the government's deal with Netflix.

DHS secretary dodges whether Russian Federation helped Trump
President Donald Trump and Russian President Vladimir Putin hold a press conference after their meeting at the Presidential Palace in Helsinki, Finland, July 16, 2018.

Iran Nuclear Chief Says Uranium Stockpile Reaches 950 Tons
That deal saw most global sanctions on Tehran lifted in exchange for strict but temporary restrictions on Iran's nuclear work.

Fiat Chrysler names new CEO
Briton Mike Manley , former head of the Jeep division of Fiat , has been named as chief executive of the Fiat Chrysler group. The CEO of FCA since 2004, Marchionne has long said he anticipated stepping down in 2019.

Watch Round 3 At Carnoustie Online
On his approach to Sunday, the 2014 Open champion added that the plan is "definitely to go out and hit a lot of drivers". He said he was thinking more about the outcome than the shots, and vowed to make sure that doesn't happen again.

Suspect Takes Hostages at Los Angeles Trader Joes
Another Eastsider reader on Facebook said the police chase went right past her at Hyperion and Rowena. The incident began as a pursuit from Hollywood that ended with a auto crashing next to the store.

Rosenstein defends charging foreign agents US can’t arrest
The first chapter is dedicated to countering malign foreign influence operations, specifically when it comes to elections. The Russian effort to influence the 2016 presidential election is "just one tree in a growing forest", Rosenstein said.

© 2015 ExpressNewsline. All Rights reserved.